Barclays’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,200
Closed -$137K 7039
2019
Q3
$137K Buy
+2,200
New +$147K ﹤0.01% 5239
2019
Q2
Sell
-100
Closed -$7K 7450
2019
Q1
$7K Sell
100
-1,400
-93% -$89.8K ﹤0.01% 6655
2018
Q4
$85K Buy
+1,500
New +$92.5K ﹤0.01% 5153
2016
Q4
Sell
-1,000
Closed -$54K 6931
2016
Q3
$54K Buy
+1,000
New +$60.3K ﹤0.01% 4935
2014
Q4
Sell
-4,200
Closed -$227K 7714
2014
Q3
$227K Buy
+4,200
New +$241K ﹤0.01% 4628
2014
Q1
Sell
-1,100
Closed -$65K 7769
2013
Q4
$65K Buy
+1,100
New +$65.7K ﹤0.01% 6001
2013
Q3
Sell
-3,000
Closed -$168K 7676
2013
Q2
$168K Buy
+3,000
New +$157K ﹤0.01% 5352

Barclays's MGLN Position: Q1 2022 in Review

Barclays sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 44,072 shares — an estimated $4.19M sold.

Barclays first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $5.28M in Q1 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • Barclays reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
  • Barclays sold 44,072 Magellan Health Services, Inc. shares in Q1 2022, an estimated $4.19M.
  • Barclays first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
  • Barclays's Magellan Health Services, Inc. position peaked at $5.28M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.